Fore Biotherapeutics
company
About
We are a precision oncology company pioneering the development of cancer therapies guided by our proprietary functional genomics.
- 1 - 10
Details
- Last Funding Type
- Series Unknown
- Last Funding Money Raised
- $6M
- Industries
- Biotechnology,Health Care,Health Diagnostics,Life Science,Medical,Personal Health
- Founded date
- Jan 1, 2011
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$16M
Fore Biotherapeutics has raised a total of
$16M
in funding over 2 rounds. Their latest funding was raised on
Apr 30, 2018 from a Series Unknown round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Apr 30, 2018 | Series Unknown | $6M | 1 |
|
— | Detail |
| Dec 23, 2015 | Series Unknown | $10M | 1 |
InterCure
|
— | Detail |
Investments
Number of Investments
Number of Lead Investments
32
2
Fore Biotherapeutics has made 32 investments. Their most recent investment was on
Oct 28, 2021, when nft42 raised $3.50M.
|
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|
|
Oct 28, 2021
nft42
|
Seed | $3.50M | Art | — |
|
Aug 10, 2021
Saturn Technologies
|
Series Unknown | $44M | Apps | — |
|
Mar 30, 2021
SuperRare
|
Series A | $9M | Bitcoin | — |
|
Jan 1, 2021
NCX
|
Seed | $4.40M | Biometrics | — |
|
Dec 3, 2020
NCX
|
Seed | $4.39M | Biometrics | — |
Investors
Number of Lead Investors
Number of Investors
2
2
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
Yes | Series Unknown |
|
InterCure
|
Yes | Series Unknown |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
